{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T23:36:35Z","timestamp":1742945795413,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":107,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493933853"},{"type":"electronic","value":"9781493933877"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_1","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T07:08:16Z","timestamp":1460617696000},"page":"3-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Impact of Vaccine Development"],"prefix":"10.1007","author":[{"given":"Puja H.","family":"Nambiar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro Delgado","family":"Daza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Lawrence L.","family":"Livornese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"1_CR1","volume-title":"Vaccina, vaccination, vaccinology: Jenner, Pasteur and their successors","author":"AK Leung","year":"1996","unstructured":"Leung AK (1996) Variolation and vaccination in late imperial China, CA 1570-1911. In: Plotkin SA, Fantini B (eds) Vaccina, vaccination, vaccinology: Jenner, Pasteur and their successors. Elsevier, Paris"},{"key":"1_CR2","first-page":"29","volume":"78","author":"N Nathanson","year":"1963","unstructured":"Nathanson N, Langmuir AD (1963) The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. Am J Hyg 78:29\u201360","journal-title":"Am J Hyg"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0140-6736(10)60175-4","volume":"375","author":"Editors of the Lancet","year":"2010","unstructured":"Editors of the Lancet (2010) Retraction Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375:445","journal-title":"Lancet"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"c7452","DOI":"10.1136\/bmj.c7452","volume":"342","author":"F Godlee","year":"2011","unstructured":"Godlee F, Smith J, Marcovitch H (2011) Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ 342:c7452","journal-title":"BMJ"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1017\/S031716710000528X","volume":"33","author":"A Doja","year":"2006","unstructured":"Doja A, Roberts W (2006) Immunizations and autism: a review of the literature. Can J Neuro Sci 33:341\u2013346","journal-title":"Can J Neuro Sci"},{"key":"1_CR6","volume-title":"International Union of Microbiological Societies, Virology Division. Virus Taxonomy: Eight report of the International Committee on Taxonomy of Viruses","author":"CM Fauquet","year":"2005","unstructured":"Fauquet CM, Mayo MA, Maniloff J et al (2005) International Union of Microbiological Societies, Virology Division. Virus Taxonomy: Eight report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA"},{"key":"1_CR7","first-page":"1","volume":"97","author":"JH Dingle","year":"1968","unstructured":"Dingle JH, Langmuir AD (1968) Epidemiology of acute respiratory disease in military recruits. Am Rev Respir Dis 97:1\u201365","journal-title":"Am Rev Respir Dis"},{"key":"1_CR8","first-page":"29","volume":"66","author":"M Hilleman","year":"1957","unstructured":"Hilleman M, Gauld R, Butler R et al (1957) Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. Am J Hyg 66:29\u201341","journal-title":"Am J Hyg"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oxfordjournals.aje.a120913","volume":"89","author":"JP Fox","year":"1969","unstructured":"Fox JP, Brandt CD, Wassermann FE et al (1969) The virus watch program: a continuing surveillance of viral infections in metropolitan New York families VI: observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, pattern of infections, and relation to illness. Am J Epidemiol 89:25\u201350","journal-title":"Am J Epidemiol"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/milmed\/160.6.300","volume":"160","author":"CA Gaydos","year":"1995","unstructured":"Gaydos CA, Gaydos JC (1995) Adenovirus vaccines in the U.S. military. Mil Med 160:300\u2013304","journal-title":"Mil Med"},{"key":"1_CR11","unstructured":"www.cdc.gov\/vaccines\/adenovirus"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4269\/ajtmh.2000.62.613","volume":"6","author":"RN Hyer","year":"2000","unstructured":"Hyer RN, Howell MR, Ryan MA et al (2000) Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits. Am J Trop Med Hyg 6:613\u2013618","journal-title":"Am J Trop Med Hyg"},{"key":"1_CR13","unstructured":"(2011) Adenovirus type 4 and adenovirus type 7 vaccine, live, oral (package insert). Teva Pharmaceuticals USA Inc, Sellersville, PA"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMra012892","volume":"345","author":"MN Schwartz","year":"2001","unstructured":"Schwartz MN (2001) Recognition and management of anthrax: an update. N Engl J Med 345:1621\u20131626","journal-title":"N Engl J Med"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(10)60573-9","volume":"375","author":"MG Booth","year":"2010","unstructured":"Booth MG, Hood J, Brooks TJ (2010) Anthrax infection in drug users. Lancet 375:1345\u20131346","journal-title":"Lancet"},{"key":"1_CR16","first-page":"1","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","unstructured":"Centers for Disease Control and Prevention (2008) Summary of notifiable diseases, United States. MMWR 57:1\u201394","journal-title":"MMWR"},{"issue":"RR-6","key":"1_CR17","first-page":"1","volume":"59","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention (2009) Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization of Practices (ACIP). MMWR 59(RR-6):1\u201330","journal-title":"MMWR"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJM198002073020601","volume":"302","author":"PA Blake","year":"1980","unstructured":"Blake PA, Allegra DT, Snyder JD et al (1980) Cholera: a possible endemic focus in the United States. N Engl J Med 302:305\u2013309","journal-title":"N Engl J Med"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1128\/IAI.66.2.692-695.1998","volume":"66","author":"CO Tacket","year":"1998","unstructured":"Tacket CO, Taylor RK, Losonsky G et al (1998) Investigation of the role of toxin coregulated pili and mannose- sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae 0139 infection. Infect Immun 66:692\u2013695","journal-title":"Infect Immun"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/IAI.74.4.2072-2079.2006","volume":"74","author":"A Silva","year":"2006","unstructured":"Silva A, Leitch G, Camilli A et al (2006) Contribution of hemagglutination\/protease and motility to pathogenesis of El Tor biotype cholera. Infect Immun 74:2072\u20132079","journal-title":"Infect Immun"},{"key":"1_CR21","unstructured":"www.who.int\/cholera\/vaccines"},{"key":"1_CR22","unstructured":"Epidemiology and prevention of vaccine-preventable diseases. The pink book: course textbook, 12th edn"},{"key":"1_CR23","unstructured":"(2006) Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices. MMWR 55(RR-3):1\u201334"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/shm\/16.1.97","volume":"16","author":"E Tognotti","year":"2003","unstructured":"Tognotti E (2003) Scientific triumphalism and learning from facts: bacteriology and the \u201cSpanish flu\u201d challenge of 1918. Soc Hist Med 16:97\u2013110","journal-title":"Soc Hist Med"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1084\/jem.53.4.471","volume":"53","author":"M Pittman","year":"1931","unstructured":"Pittman M (1931) Variation and type specificity in bacterial species Hemophilus influenzae. J Exp Med 53:471\u2013492","journal-title":"J Exp Med"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0022-3476(79)80571-5","volume":"94","author":"AS Dajani","year":"1979","unstructured":"Dajani AS, Asmar BI, Thirumoorthi MC (1979) Systemic Haemophilus influenzae disease: an overview. J Pediatr 94:355\u2013364","journal-title":"J Pediatr"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/jcp.36.9.991","volume":"36","author":"GM Tebbutt","year":"1983","unstructured":"Tebbutt GM (1983) Evaluation of some methods for the laboratory identification of Heamophilus influenzae. J Clin Pathol 36:991","journal-title":"J Clin Pathol"},{"key":"1_CR28","unstructured":"Centers for Disease Control and Prevention. \n                    www.cdc.gov\/vaccines\/hib"},{"key":"1_CR29","volume-title":"World Atlas of Epidemic Diseases","author":"L Bachman","year":"1952","unstructured":"Bachman L (1952) Infectious hepatitis in Europe. In: Rodenwalt E (ed) World Atlas of Epidemic Diseases. Falk-Verlag Hamburg, Germany"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000149554","volume":"22","author":"G Siegl","year":"1984","unstructured":"Siegl G, Weitz M, Kronauer G (1984) Stability of hepatitis A virus. Intervirology 22:218\u2013226","journal-title":"Intervirology"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jama.1967.03120180053006","volume":"200","author":"S Krugman","year":"1967","unstructured":"Krugman S, Giles JP, Hammond J (1967) Infectious hepatitis: evidence of two distinctive clinical, epidemiological and immunological types of infection. JAMA 200:365\u2013373","journal-title":"JAMA"},{"issue":"Suppl 1","key":"1_CR32","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/0264-410X(92)90557-Z","volume":"10","author":"J Peetermans","year":"1992","unstructured":"Peetermans J (1992) Production, quality control and characterization of an inactivated hepatitis A vaccine. Vaccine 10(Suppl 1):S99\u2013S101","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"1_CR33","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/S0168-8278(05)80373-3","volume":"18","author":"ME Armstrong","year":"1993","unstructured":"Armstrong ME, Giesa PA, Davide JP et al (1993) Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F. J Hepatol 18(Suppl 2):S20\u2013S26","journal-title":"J Hepatol"},{"key":"1_CR34","unstructured":"Atkinson W, Wolfe S, Hamborsky J (2012) Epidemiology and prevention of vaccine-preventable diseases, 12th edn, 2nd printing. Public Health Foundation, Centers for Disease Control and Prevention, Washington DC"},{"key":"1_CR35","unstructured":"(2006) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR 55(RR-16):1\u201333"},{"issue":"5","key":"1_CR36","first-page":"1108","volume":"11","author":"J Li","year":"2015","unstructured":"Li J, Yao J, Shan H, Chen Y, Jiang ZG, Ren JJ, Xu KJ, Ruan B, Yang SG, Wang B, Xie TS, Li Q (2015) Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults. Hum Vaccin Immunother 11(5):1108\u20131113","journal-title":"Hum Vaccin Immunother"},{"key":"1_CR37","first-page":"CD009886","volume":"10","author":"MP Okwen","year":"2014","unstructured":"Okwen MP, Reid S, Njei B, Mbuagbaw L (2014) Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection. Cochrane Database Syst Rev 10:CD009886","journal-title":"Cochrane Database Syst Rev"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2010.02.002","volume":"401","author":"HU Bernard","year":"2010","unstructured":"Bernard HU, Burk RD, Chen Z et al (2010) Classification of papillomaviruses based on 189 PV types and proposal of taxonomic amendments. Virology 401:79","journal-title":"Virology"},{"key":"1_CR39","first-page":"2299","volume-title":"Fields virology","author":"PM Howley","year":"2007","unstructured":"Howley PM, Lowy DR (2007) Papillomaviruses. In: Knipe DM, Howley PH (eds) Fields virology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 2299\u20132354","edition":"5"},{"issue":"suppl 3","key":"1_CR40","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) Chapter 2. The burden of HPV-related cancers. Vaccine 24(suppl 3):S11\u2013S25","journal-title":"Vaccine"},{"key":"1_CR41","first-page":"59","volume":"321","author":"G Orth","year":"2008","unstructured":"Orth G (2008) Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol 321:59\u201383","journal-title":"Curr Top Microbiol Immunol"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","volume":"80","author":"M Durst","year":"1983","unstructured":"Durst M, Gissman L, Ikenberg H et al (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence I cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 80:3812\u20133815","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J et al (2007) Human papillomavirus and cervical cancer. Lancet 370:890\u2013907","journal-title":"Lancet"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMoa065497","volume":"356","author":"G D'Souza","year":"2007","unstructured":"D'Souza G, Kreimer AR, Viscidi R et al (2007) Case\u2013control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944\u20131956","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"1_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.vaccine.2006.05.119","volume":"24","author":"S Inglis","year":"2006","unstructured":"Inglis S, Shaw A, Koenig S (2006) Chapter 11: HPV vaccines: commercial research and development. Vaccine 24(suppl 3):99\u2013105","journal-title":"Vaccine"},{"key":"1_CR46","unstructured":"Centers for Disease Control and Prevention. \n                    www.cdc.gov\/vaccines\/hpv"},{"key":"1_CR47","unstructured":"Atkinson W, Wolfe S, Hamborsky J (2012) Centers for Disease Control and Prevention Epidemiology and prevention of vaccine-preventable diseases, 12th edn, 2nd printing. Public Health Foundation, Washington, DC"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","volume":"292","author":"WW Thompson","year":"2004","unstructured":"Thompson WW, Shay DK, Weintraub E et al (2004) Influenza-associated hospitalizations in the United States. JAMA 292:1333\u20131340","journal-title":"JAMA"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa055778","volume":"354","author":"JJ Treanor","year":"2006","unstructured":"Treanor JJ, Campbell JD, Zangwill KM et al (2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354:1343\u20131351","journal-title":"N Engl J Med"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","volume":"12","author":"MT Osterholm","year":"2012","unstructured":"Osterholm MT, Kelley NS, Sommer A, Belongia EA (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12:36\u201344","journal-title":"Lancet Infect Dis"},{"issue":"33","key":"1_CR51","first-page":"1128","volume":"60","author":"CDC","year":"2011","unstructured":"CDC (2011) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices. MMWR 60(33):1128\u20131132","journal-title":"MMWR"},{"key":"1_CR52","unstructured":"Center for Disease Control and Prevention: Japanese Encephalitis vaccine. \n                    www.cdc.gov\/japaneseencephalitis\/vaccine"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(97)07509-0","volume":"351","author":"T Solomon","year":"1998","unstructured":"Solomon T, Kneen R, Dung NM et al (1998) Poliomyelitis -like illness due to Japanese encephalitis virus. Lancet 351:1094\u20131097","journal-title":"Lancet"},{"key":"1_CR54","unstructured":"(2013) Center for Disease Control and Prevention: Japanese Encephalitis vaccines: ACIP recommendations. MMWR"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1017\/S0950268800066449","volume":"99","author":"KA Cartwright","year":"1987","unstructured":"Cartwright KA, Stuart JM, Jones DM, Noah ND (1987) The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 99:591\u2013601","journal-title":"Epidemiol Infect"},{"key":"1_CR56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/JCM.32.2.323-330.1994","volume":"32","author":"DA Caugant","year":"1994","unstructured":"Caugant DA, Hoiby EA, Magnus P et al (1994) Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 32:323\u2013330","journal-title":"J Clin Microbiol"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","volume":"10","author":"H Christensen","year":"2010","unstructured":"Christensen H, May M, Bowen L et al (2010) Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 10:853\u2013861","journal-title":"Lancet Infect Dis"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/clinids\/18.5.780","volume":"18","author":"CA Fijenn","year":"1994","unstructured":"Fijenn CA, Kuijper EJ, Tjia HG et al (1994) Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria -related bacteria. Clin Infect Dis 18:780\u2013784","journal-title":"Clin Infect Dis"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-2249.1999.01057.x","volume":"118","author":"SM Linton","year":"1999","unstructured":"Linton SM, Morgan BP (1999) Properdin deficiency and meningococcal disease: identifying those most at risk. Clin Exp Immunol 118:189\u2013191","journal-title":"Clin Exp Immunol"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/bmj.308.6931.792c","volume":"308","author":"RJ Condon","year":"1994","unstructured":"Condon RJ, Riley TV, Kelly H (1994) Invasive meningococcal infection after splenectomy. BMJ 308:792\u2013793","journal-title":"BMJ"},{"key":"1_CR61","unstructured":"Bilukha OO, Rosenstein N (2005) Prevention and control of meningococcal disease: recommendations of the ACIP. MMWR"},{"key":"1_CR62","unstructured":"Report from the ACIP (2008) decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal vaccine (MCV4). MMWR"},{"key":"1_CR63","unstructured":"Licensure of meningococcal conjugate vaccine (Menveo) and guidance for use (2010) ACIP MMWR"},{"key":"1_CR64","unstructured":"Center for Disease Control and Prevention (2014) ACIP recommendations for meningococcal vaccinations. MMWR"},{"key":"1_CR65","volume-title":"A discourse on the smallpox and measles","author":"M Abu Becr","year":"1748","unstructured":"Abu Becr M (1748) A discourse on the smallpox and measles. J Brindley, London"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/archpedi.1962.02080020530077","volume":"103","author":"GS Wilson","year":"1962","unstructured":"Wilson GS (1962) Measles as a universal disease. Am J Dis Child 103:219\u2013223","journal-title":"Am J Dis Child"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/978-1-4613-0705-1_16","volume-title":"Viral infections of humans: epidemiology and control","author":"FL Black","year":"1989","unstructured":"Black FL, Evans AS (1989) Viral infections of humans: epidemiology and control, 3rd edn. Plenum, New York, pp 451\u2013465","edition":"3"},{"key":"1_CR68","first-page":"224","volume":"103","author":"AD Langmuir","year":"1962","unstructured":"Langmuir AD (1962) Medical importance of measles. Am J Dis Child 103:224\u2013226","journal-title":"Am J Dis Child"},{"key":"1_CR69","first-page":"1321","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention (2009) Global measles mortality. MMWR 58:1321\u20131326","journal-title":"MMWR"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1017\/S0263593300027280","volume":"2","author":"R Hamilton","year":"1790","unstructured":"Hamilton R (1790) An account of a distemper by the common people of England vulgarly called the mumps. Trans Roy Soc Edinb 2:59\u201372","journal-title":"Trans Roy Soc Edinb"},{"key":"1_CR71","first-page":"46","volume":"21","author":"CD Johnson","year":"1935","unstructured":"Johnson CD, Goodpasture EW (1935) The etiology of mumps. Am J Hyg 21:46\u201357","journal-title":"Am J Hyg"},{"key":"1_CR72","first-page":"338","volume":"200","author":"JE Gordon","year":"1940","unstructured":"Gordon JE, Heeren RH (1940) The epidemiology of mumps. Am J Med Sci 200:338\u2013359","journal-title":"Am J Med Sci"},{"key":"1_CR73","volume-title":"Handbook of Geographical and Historical Pathology. Volume I: acute infective diseases","author":"A Hirsch","year":"1883","unstructured":"Hirsch A (1883) Handbook of Geographical and Historical Pathology. Volume I: acute infective diseases, 2nd edn. Sydenham Society London, England","edition":"2"},{"key":"1_CR74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a120882","volume":"88","author":"K Penttinen","year":"1968","unstructured":"Penttinen K, Cantell K, Somer P et al (1968) Mumps vaccination in the Finnish defense forces. Am J Epidemiol 88:234\u2013244","journal-title":"Am J Epidemiol"},{"key":"1_CR75","first-page":"1","volume":"1","author":"JL Smith","year":"1875","unstructured":"Smith JL (1875) Rotheln (epidemic roseola-German measles-hybrid measles). Arch Dermatol 1:1\u201313","journal-title":"Arch Dermatol"},{"key":"1_CR76","first-page":"404","volume":"12","author":"H Veale","year":"1866","unstructured":"Veale H (1866) History of an epidemic of rotheln with observation on its pathology. Edinb Med J 12:404\u2013414","journal-title":"Edinb Med J"},{"key":"1_CR77","first-page":"35","volume":"3","author":"NM Gregg","year":"1941","unstructured":"Gregg NM (1941) Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3:35\u201346","journal-title":"Trans Ophthalmol Soc Aust"},{"key":"1_CR78","unstructured":"Measles, mumps, and rubella- vaccine use and strategies (1998) Recommendations of the Advisory Committee on Immunization Practices. MMWR 1\u20135"},{"key":"1_CR79","unstructured":"Atkinson W, Wolfe S, Hamborsky J (2012) Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine, 12th edn, 2nd printing. Washington, DC: Public Health Foundation"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1086\/320754","volume":"32","author":"LD Senzilet","year":"2001","unstructured":"Senzilet LD, Halperin SA, Spika JS et al (2001) Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 32:1691\u20131697","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1_CR81","first-page":"13","volume":"60","author":"CDC","year":"2011","unstructured":"CDC (2011) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices (ACIP). MMWR 60(1):13\u201315","journal-title":"MMWR"},{"key":"1_CR82","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention (2012) Epidemiology and prevention of vaccine-preventable diseases. Public Health Foundation, Washington, DC"},{"issue":"1","key":"1_CR83","doi-asserted-by":"publisher","first-page":"e00309","DOI":"10.1128\/mBio.00309-10","volume":"2","author":"L Simonsen","year":"2011","unstructured":"Simonsen L, Taylor RJ, Young-Xu Y et al (2011) Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2(1):e00309\u2013e00310","journal-title":"MBio"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","volume":"285","author":"KA Robinson","year":"2001","unstructured":"Robinson KA, Baughman W, Rothrock G (2001) Epidemiology of invasive Streptococcus pneumoniae infections in the United States 1995\u20131998. Opportunities for prevention in the conjugate vaccine era. JAMA 285:1729\u20131735","journal-title":"JAMA"},{"issue":"1","key":"1_CR85","doi-asserted-by":"publisher","first-page":"e00309","DOI":"10.1128\/mBio.00309-10","volume":"2","author":"L Simonsen","year":"2011","unstructured":"Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP (2011) Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2(1):e00309\u2013e00310","journal-title":"MBio"},{"key":"1_CR86","unstructured":"http:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/vacc-specific\/pneumo.html"},{"key":"1_CR87","first-page":"705","volume":"70","author":"C Bern","year":"1992","unstructured":"Bern C, Martines J, De Zoysa I (1992) The magnitude of the global problem of diarrheal disease: a ten-year update. Bull World Health Organ 70:705\u2013714","journal-title":"Bull World Health Organ"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","volume":"375","author":"RE Black","year":"2008","unstructured":"Black RE, Cousens S, Johnson HL et al (2008) Global, regional, and national causes of child mortality: a systematic analysis. Lancet 375:1969\u20131987","journal-title":"Lancet"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3201\/eid0905.020562","volume":"9","author":"UD Parashar","year":"2003","unstructured":"Parashar UD, Burton A, Lanata C et al (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565\u2013572","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"1_CR90","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/infdis\/174.Supplement_1.S5","volume":"174","author":"RI Glass","year":"1996","unstructured":"Glass RI, Kilgore PE, Holman RC et al (1996) The epidemiology of rotavirus diarrhea in the United States: surveillance and estimated of disease burden. J Infect Dis 174(Suppl 1):S5\u2013S11","journal-title":"J Infect Dis"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jama.1995.03530140055032","volume":"274","author":"PE Kilgore","year":"1995","unstructured":"Kilgore PE, Holman RC, Clarke MJ et al (1995) Trends of diarrheal disease- associated mortality in U.S. children, 1968 through 1991. JAMA 274:1143\u20131148","journal-title":"JAMA"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1126\/science.272.5258.101","volume":"272","author":"JM Ball","year":"1996","unstructured":"Ball JM, Tian P, Zeng C et al (1996) Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272:101\u2013104","journal-title":"Science"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/jmv.1890140206","volume":"14","author":"I Perez-Schael","year":"1984","unstructured":"Perez-Schael I, Daoud G, White L et al (1984) Rotavirus shedding in newborn children. J Med Virol 14:127\u2013136","journal-title":"J Med Virol"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0140-6736(78)90967-4","volume":"1","author":"IL Chrystie","year":"1978","unstructured":"Chrystie IL, Totterdell BM, Banatvala JE (1978) Asymptomatic endemic rotavirus infections in the newborn. Lancet 1:1176\u20131178","journal-title":"Lancet"},{"key":"1_CR95","unstructured":"Centers for Disease Control and Prevention (2014) ACIP rotavirus vaccine recommendations. MMWR"},{"key":"1_CR96","unstructured":"Centers for Disease Control and Prevention (2012) Epidemiology and prevention of vaccine-preventable diseases"},{"key":"1_CR97","unstructured":"(2011) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices. MMWR 60(1):13\u201315"},{"issue":"12","key":"1_CR98","first-page":"365","volume":"60","author":"Morbidity and Mortality Weekly Report","year":"2011","unstructured":"Morbidity and Mortality Weekly Report (2011) Tetanus surveillance United States, 2001\u20132008. MMWR 60(12):365\u2013369","journal-title":"MMWR"},{"key":"1_CR99","unstructured":"Plotkin SA, Orenstein WA, Offit PA (eds) Vaccines, 6th edn"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz BB, Fine PEM, Dye C (2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367:1173\u20131180","journal-title":"Lancet"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","volume":"22","author":"LC Rodriques","year":"1993","unstructured":"Rodriques LC, Diwan VK, Wheeler JG (1993) Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 22:1154\u20131158","journal-title":"Int J Epidemiol"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1016\/j.vaccine.2013.09.030","volume":"31","author":"E Rafferty","year":"2013","unstructured":"Rafferty E, Duclos P, Yactayo S, Schuster M (2013) Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review. Vaccine 31:5798\u20135805","journal-title":"Vaccine"},{"key":"1_CR103","unstructured":"Centers for Disease Control and Prevention (2012) Epidemiology and prevention of vaccine-preventable diseases"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/528696","volume":"197","author":"MJ Levin","year":"2008","unstructured":"Levin MJ, Oxman MN, Zhang JH et al (2008) Varicella-zoster virus\u2013specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 197:825\u2013835","journal-title":"J Infect Dis"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J et al (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209\u20132220","journal-title":"N Engl J Med"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"13151","DOI":"10.1073\/pnas.1414148111","volume":"111","author":"T-W Chuna","year":"2014","unstructured":"Chuna T-W, Murraya D, Justementa JS et al (2014) Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir. Proc Natl Acad Sci U S A 111:13151\u201313156","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1056\/NEJMp1312711","volume":"369","author":"MD Barouch","year":"2013","unstructured":"Barouch MD (2013) The quest for an HIV-1 vaccine-moving forward. N Engl J Med 369:2073\u20132076","journal-title":"N Engl J Med"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T15:26:00Z","timestamp":1580311560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"14 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}